I’ve been diving into this year’s market research and noticed some significant shifts in biotech sales strategies, especially with the rise of personalized medicine. It’s fascinating how companies are leveraging AI for competitive analysis, and I wonder how others are adapting. Has anyone here seen notable changes in their sales approach or outcomes?